Germline BRCA1 mutation and survival analysis in familial breast cancer patients in Kerala; South India

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 3, 2007, Pages 329-336

  Vinodkumar, B ^a   Syamala, V ^a   Abraham, E K ^a   Balakrishnan, R ^a   Ankathil, Ravindran ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

185delAG; BRCA1; Breast cancer; CSGE; Survival analysis

Indexed keywords

BRCA1 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GEL ELECTROPHORESIS; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GERM LINE; HISTOPATHOLOGY; HUMAN; INDIA; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INDIA; SURVIVAL ANALYSIS;

EID: 35348894287     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gajalakshmi C.K., Shanta V., Swaminathan R., et al.: Population-based survival study on female breast cancer in Madras, India. Br. J. Cancer. 75:771-775, 1997.
2. Kelsey J.L., Gammon M.D.: The epidemiology of breast cancer. CA Cancer J. Clin. 41:146-165, 1991.
3. Miki Y., Swensen J., Shattuck-Eidens D., et al.: Strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:66-71, 1994.
4. Wooster R., Bignell G., Lancaster J., et al.: Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:789-792, 1995.
5. Neuhausen S.L.: Ethnic differences in cancer risk resulting from genetic variation. Cancer. 86:2575-2582, 1999.
6. Porter D.E., Cohen B.B., Wallace M.R., et al.: Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br. J. Surg. 81:1512-1515, 1994.
7. Marcus J.N., Watson P., Page D.L., et al. ; Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer. 77:697-709,1996.
8. Foulkes W.D., Wong N., Brunet J.S., et al.: Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin. Cancer Res. 3: 2465-2469, 1997.
9. Eerola H., Vahteristo P., Sarantaus L., et al.: Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. Int. J. Cancer. 93:368-372, 2001.
10. Kumar B.V., Lakhotia S., Ankathil R., et al.: Germline BRCA1 mutation analysis in Indian breast/ovarian cancer families. Cancer Biol. Ther. 1:18-21, 2002.
11. Ganguly A., Rock M.J., Prockop D.J.: Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc. Natl Acad. Sci. U.S.A. 90:10325-10329, 1993.
12. Ganguly A., Leahy K., Marshall A.M.,et al.: Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Genet. Test. 1:85-90, 1997.
13. Markoff A., Sormbroen H., Bogdanova N., et al.: Comparison of conformation-sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols. Eur. J. Hum. Genet. 6:145-150, 1998.
14. De Benedetti V.M., Radice P., Mondini P., et al. ; Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test. Oncogene. 13:1353-1357, 1996.
15. Caligo M.A., Ghimenti C., Cipollini G., et al.; BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations. Oncogene.13:1483-1488, 1996.
16. Montagna M., Santacatterina M., Corneo B., et al.: Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res. 56:5466-5469, 1996.
17. Thorlacius S., Olafsdottir G., Tryggvadottir L., et al.: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet. 13:117-119, 1996.
18. Gayther S.A., Harrington P., Russell P.,et al.: Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am. J. Hum. Genet. 60:1239-1242,1997.
19. Saxena S., Szabo C.I., Chopin S., et al.: BRCA1 and BRCA2 in Indian breast cancer patients. Hum. Mutat. 20:473-474, 2002.
20. Kang H.C., Kim I.J., Park J.H., et al.: Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families. Hum. Mutat. 20:235, 2002.
21. Osorio A., Barroso A., Martinez B., et al.: Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br. J. Cancer 2000;82:1266-1270.
22. Dong J., Chang-Claude J., Wu Y., et al.: A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3′ third of the gene. Hum. Genet. 103:154-161, 1998.
23. Neuhausen S.L., Mazoyer S., Friedman L., et al.: Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am. J. Hum. Genet. 58:271-280, 1996.
24. Szabo C.I., King M.C.: Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet. 60:1013-1020, 1997.
25. Breast cancer Information Core (BIC). http://www.nhgri.nih.gov/ Intramural_research/Lab_transfer/Bic/
26. Valarmathi M.T., Sawhney M., Deo S.S., et al.: Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. Hum. Mutat. 23:205, 2004.
27. Struewing J.P., Abeliovich D., Peretz T., et al.: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet. 11:198-200, 1995.
28. Roa B.B., Boyd A.A., Volcik K., et al.: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat. Genet. 14:185-187, 1996.
29. Berman D.B., Wagner-Costalas J., Schultz D.C., et al.: Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am. J. Hum. Genet. 58:1166-1176,1996.
30. Xu C.F., Chambers J.A., Nicolai H., et al.: Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosome Cancer. 18:102-110,1997.
31. Bar-Sade R.B., Kruglikova A., Modan B., et al.: The 185de-1AG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum. Mol. Genet.7: 801-805, 1998.
32. Wang SC., Lin S.H., Su L.K., et al.: Changes in BRCA2 expression during progression of the cell cycle. Biochem. Biophys Res. Commun. 234: 247-251,1997.
33. Wooster R., Neuhausen S.L., Mangion J., et al.: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 265:2088-2090, 1994.
34. Ansquer Y., Gautier C., Fourquet A., et al.: Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group. Lancet. 352:541m,1998.
35. Chappuis P.O., Rosenblatt J., Foulkes WD.: The influence of familial and hereditary factors on the prognosis of breast cancer. Ann.Oncol. 10:1163-1170, 1999.
36. Phillips K.A., Andrulis I.L., Goodwin P.J.: Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different? J. Clin .Oncol. 17:3653-3663, 1999.
37. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet. 349:1505-10, 1997.
38. Eisinger F., Stoppa-Lyonnet D., Longy M., et al.: Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res. 56:471-474, 1996.
39. Sobol H., Stoppa-Lyonnet D., Bressac-De-Paillerets B.,et al.: Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res.56: 3216-3219, 1996.